scholarly journals Botulinum Toxin A for the Treatment of a Child with SUNCT Syndrome

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Yi Zhang ◽  
Haifeng Zhang ◽  
Ya-Jun Lian ◽  
Yun-Qing Ma ◽  
Nan-Chang Xie ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
First Episode ◽  
Toxin A ◽  
Temporal Area ◽  
Subcutaneous Injections ◽  
Sunct Syndrome ◽  
Therapeutic Benefits ◽  
Inflammatory Drugs

Background.Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) syndrome is an unusual cause of headache, mainly described in older adults, and is rare in children. Pain attacks may be severe, frequent, and prolonged. The therapeutic benefits of many drugs are disappointing.Patient and Methods.A 12-year-old boy suffered severe headache and toothache for 20 days. As treatment with nonsteroidal anti-inflammatory drugs, anticonvulsants, and steroids proved ineffective, he was treated with ipsilateral multisite subcutaneous injections of botulinum toxin A 70 U around the orbit, the temporal area, and the upper gum.Results.The pain had reduced in frequency and severity by the fourth day after treatment and had completely disappeared after 7 days. There were no side effects or recurrence during a subsequent 17-month follow-up period.Conclusion.Botulinum toxin A can be used to treat the first episode of SUNCT in children over the age of 12 years.

scholarly journals Botulinum Toxin A Injection for Treatment of Chronic Skin Ulcer: A Case Series and Literature Review

2019 ◽  
Vol 18 (1) ◽  
pp. 97-103
Author(s):  
Jiaojiao Zhong ◽  
Yu Lan ◽  
Shuying Fu ◽  
Jing Zhang ◽  
Sha Lu ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
Case Series ◽  
Skin Ulcer ◽  
Review Of The Literature ◽  
Toxin A ◽  
Subcutaneous Injections ◽  
Skin Ulcers ◽  
Chronic Skin ◽  
Ulcer Treatment

Chronic skin ulcer (CSU) often combines with a variety of refractory factors that respond poorly to routine treatments. Botulinum toxin A (BTX-A) can be injected subcutaneously to improve the local blood supply, to reduce pain, and to promote wound healing. At present, few reports have mentioned BTX-A injection for chronic skin ulcer treatment. We observed the effect of four cases that used BTX-A to treat CSU and provided a brief review of the literature. Four cases of CSUs with 4 different causes were treated with BTX-A injection (4 U/cm2). The specific operation is as follows: local, multipoint, cyclic, equidistant, and subcutaneous injections with a depth of 6 to 8 mm. The ulcer area was significantly reduced. Subsequently, the ulcer healed within 20 to 48 days. Botulinum toxin A is recommended as an important treatment for chronic skin ulcer that can improve healing of skin ulcers with various etiologies.

scholarly journals Therapeutic effect of Botulinum toxin-A in 88 patients with Trigeminal Neuralgia with 14-month follow-up

2014 ◽  
Vol 15 (1) ◽  
Author(s):  
Shuang Li ◽  
Ya-Jun Lian ◽  
Yuan Chen ◽  
Hai-Feng Zhang ◽  
Yun-Qing Ma ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Trigeminal Neuralgia ◽  
Therapeutic Effect ◽  
Botulinum Toxin A ◽  
Toxin A

1.254 Long-term follow-up of cervical dystonia patients treated with Botulinum toxin A

2007 ◽  
Vol 13 ◽  
pp. S66
Author(s):  
K. Kollewe ◽  
N. Buhr ◽  
K. Krampfl ◽  
R. Dengler ◽  
B. Mohammadi
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin A ◽  
Toxin A ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document